Loading...
Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection
Muinonen-Martin, A. Lee, Rebecca J Rothwell, Dominic G Jackson, R. Smith, Nigel Wong, S. Kelso, N. Hewitt, C. Mitchell, Jackie Jones, K.
Muinonen-Martin, A.
Lee, Rebecca J
Rothwell, Dominic G
Jackson, R.
Smith, Nigel
Wong, S.
Kelso, N.
Hewitt, C.
Mitchell, Jackie
Jones, K.
Citations
Altmetric:
Abstract
Authors
Muinonen-Martin, A.
Lee, Rebecca J
Rothwell, Dominic G
Jackson, R.
Smith, Nigel
Wong, S.
Kelso, N.
Hewitt, C.
Mitchell, Jackie
Jones, K.
Turajlic, S.
Corrie, P.
Marais, R.
Middleton, M.
Dawson, S. J.
Sandhu, S.
Dive, Caroline
Lorigan, Paul C
Lee, Rebecca J
Rothwell, Dominic G
Jackson, R.
Smith, Nigel
Wong, S.
Kelso, N.
Hewitt, C.
Mitchell, Jackie
Jones, K.
Turajlic, S.
Corrie, P.
Marais, R.
Middleton, M.
Dawson, S. J.
Sandhu, S.
Dive, Caroline
Lorigan, Paul C
Affiliation
Leeds Teaching Hospitals NHS Trust, Leeds, UK
Description
Date
2023
Publisher
Collections
Files
Keywords
Type
Meetings and Proceedings
Citation
Muinonen-Martin A, Lee R, Rothwell D, Jackson R, Smith N, Wong S, et al. Trial redesign for the phase II/III DETECTION trial: circulating tumour DNA-guided therapy for stage IIB/C melanoma after surgical resection. British Journal of Dermatology. 2023 Jun;188. PubMed PMID: WOS:001023058900083.